SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 1,203.39 |
Enterprise Value ($M) | 1,056.06 |
Book Value ($M) | 421.44 |
Book Value / Share | 6.60 |
Price / Book | 2.86 |
NCAV ($M) | 233.21 |
NCAV / Share | 3.65 |
Price / NCAV | 5.16 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.35 |
Return on Assets (ROA) | -0.25 |
Return on Equity (ROE) | -0.36 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 3.31 |
Current Ratio | 3.31 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 634.99 |
Assets | 823.23 |
Liabilities | 401.78 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 207.54 |
Operating Income | -209.30 |
Net Income | -187.12 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -157.37 |
Cash from Investing | 148.84 |
Cash from Financing | 10.12 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Rubric Capital Management LP | 7.85 | 35.67 | |
13G | Sumitomo Mitsui Trust Holdings, Inc. | 5.50 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
204,661 | 713,050 | 28.70 | |
315,603 | 1,019,790 | 30.95 | |
152,638 | 682,116 | 22.38 | |
99,395 | 550,797 | 18.05 | |
(click for more detail) |
Similar Companies | |
---|---|
RXRX – Recursion Pharmaceuticals, Inc. | SANA – Sana Biotechnology, Inc. |
SCPH – scPharmaceuticals Inc. | SLDB – Solid Biosciences Inc. |
SLRN – Acelyrin, Inc. |
Financial data and stock pages provided by
Fintel.io